BackAdma Biologics Overview

Adma Biologics Other Income Expense Net

Other Income/Expense Net for ADMA.

Quarterly Other Income/Expense

-$1.15M
↑ 19.85% YoY

As of Mar 31, 2026

Annual Other Income/Expense (TTM)

-$8.50M
↑ 24.64% YoY

Trailing 12 months ending Mar 31, 2026

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin